Artios

DNA Damage Response | DDR Company | Artios Pharma

Artios was founded in 2016, is headquartered in Cambridge, United Kingdom, lists 51–200 employees, and has $301.2M in recorded funding across 3 rounds.

Headquarters
Cambridge
Employees
51–200
Founded
2016
Business Model
B2B
Website
artios.com
Total Funding
$301.2M
Last Round
$115.0M Series DNov 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Artios is a clinical-stage biopharmaceutical company focused on developing cancer therapies that target the DNA Damage Response pathway. Based at the Babraham Campus in Cambridge, UK, it has built a pipeline of DDR inhibitors including alnodesertib (ATR inhibitor) and a Pol Theta inhibitor program. Co-founded in 2016 by pioneering DDR researchers, Artios raised $115M in a Series D in 2025.

Summary

Artios is a Biotech company based in Cambridge, United Kingdom, founded in 2016. It lists 51–200 employees. It has raised $301.2M in total across 3 rounds, most recently a $115.0M Series D round in Nov 2025. Investors include Omega Funds, TCGX and SV Life Sciences.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DNov 2025
$115.0M

Sign up to see all 3 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Artios on Indexed.vc
<a href="https://indexed.vc/companies/artios"><img src="https://indexed.vc/api/badge/company/artios" alt="Artios on Indexed.vc" width="260" height="76" /></a>